Loading...
About this Episode
What are the major obstacles that prevent effective anti-aging therapies from being developed?
On Sunday, December 7, 2025, at 1 p.m. U.S. Pacific Time, the U.S. Transhumanist Party presents its conversation with Ariel VA Feinerman (recorded on May 10, 2025) on the problems standing in the way of regenerative medicine aimed at reversing human aging. Ariel outlined the damage-repair approach to achieving rejuvenation, based on the insights of Dr. Aubrey de Grey and his Strategies for Engineered Negligible Senescence (SENS). Furthermore, Ariel analyzed in detail why funding from governmental sources and private investors is still largely misdirected, while such funding sources largely ignore truly promising damage-repair research and therapies that are currently capable of being tested and deployed. Ariel also explained the regulatory obstacles to the arrival of rejuvenation treatments, particularly the lengthy and outdated review processes of the U.S. Food and Drug Administration, which are poorly suited to the emerging paradigm for regenerative therapies.
In the course of his presentation, Ariel VA Feinerman received and answered questions from the USTP panel, including Chairman Gennady Stolyarov II, Allen Crowley of the Texas Transhumanist Party, Art Ramon Garcia, Jr. (Director of Visual Art), and Jason Geringer (Legislative Director).
Ariel VA Feinerman is a research scientist, author, photographer, and longevity advocate who considers it his foremost goal "to improve human health and life, and achieve biological immortality in our lifetime." He describes himself as "interested in nanomedicine, bioengineering, biomedical engineering." He has educational and professional backgrounds in rejuvenation biotechnology, physics, programming, and entomology. In 2020, he co-founded the biotechnological company IntraClear Biologics OÜ, in Tallinn, Estonia, and became its Chief Science Officer.
Read a more detailed biography of Ariel VA Feinerman and find links to his interviews with notable longevity researchers on his THPedia page at https://th-pedia.org//wiki/Ariel_VA_Feinerman.
Read Ariel VA Feinerman’s blog on Medium: https://medium.com/@arielf.
Visit the website of IntraClear Biologics at https://intraclearbiologics.com/.
Visit the website of Oisín Biotechnologies: https://www.oisinbio.com/
Visit the website of Dr. Aubrey de Grey’s Longevity Escape Velocity Foundation at https://levf.org/.
On Sunday, December 7, 2025, at 1 p.m. U.S. Pacific Time, the U.S. Transhumanist Party presents its conversation with Ariel VA Feinerman (recorded on May 10, 2025) on the problems standing in the way of regenerative medicine aimed at reversing human aging. Ariel outlined the damage-repair approach to achieving rejuvenation, based on the insights of Dr. Aubrey de Grey and his Strategies for Engineered Negligible Senescence (SENS). Furthermore, Ariel analyzed in detail why funding from governmental sources and private investors is still largely misdirected, while such funding sources largely ignore truly promising damage-repair research and therapies that are currently capable of being tested and deployed. Ariel also explained the regulatory obstacles to the arrival of rejuvenation treatments, particularly the lengthy and outdated review processes of the U.S. Food and Drug Administration, which are poorly suited to the emerging paradigm for regenerative therapies.
In the course of his presentation, Ariel VA Feinerman received and answered questions from the USTP panel, including Chairman Gennady Stolyarov II, Allen Crowley of the Texas Transhumanist Party, Art Ramon Garcia, Jr. (Director of Visual Art), and Jason Geringer (Legislative Director).
Ariel VA Feinerman is a research scientist, author, photographer, and longevity advocate who considers it his foremost goal "to improve human health and life, and achieve biological immortality in our lifetime." He describes himself as "interested in nanomedicine, bioengineering, biomedical engineering." He has educational and professional backgrounds in rejuvenation biotechnology, physics, programming, and entomology. In 2020, he co-founded the biotechnological company IntraClear Biologics OÜ, in Tallinn, Estonia, and became its Chief Science Officer.
Read a more detailed biography of Ariel VA Feinerman and find links to his interviews with notable longevity researchers on his THPedia page at https://th-pedia.org//wiki/Ariel_VA_Feinerman.
Read Ariel VA Feinerman’s blog on Medium: https://medium.com/@arielf.
Visit the website of IntraClear Biologics at https://intraclearbiologics.com/.
Visit the website of Oisín Biotechnologies: https://www.oisinbio.com/
Visit the website of Dr. Aubrey de Grey’s Longevity Escape Velocity Foundation at https://levf.org/.
Hosts & Guests
No transcript available for this episode.
